This work mitigates a big issue with the first gene drive systems, which is the accumulation of drive-resistant mosquitoes that could still transmit malaria parasites,” said UCI vector biologist Anthony James. Steve Zylius / UCI
New CRISPR-based gene drive approach successfully overcomes issue of resistance in females
Employing a strategy known as “population modification,” which involves using a CRISPR-Cas9 gene drive system to introduce genes preventing parasite transmission into mosquito chromosomes, University of California researchers have made a major advance in the use of genetic technologies to control the transmission of malaria parasites.
University of California, Irvine postdoctoral researcher Adriana Adolfi, in collaboration with colleagues at UCI, UC Berkeley and UC San Diego, followed up on the group’s pioneering effort to develop CRISPR-based gene drive systems for making mosquito vectors resistant to transmitting malaria parasites by increasing gene drive effectiveness in female mosquito progeny.
“This work mitigates a big issue with the first gene drive systems, which is the accumulation of drive-resistant mosquitoes that could still transmit malaria parasites,” said UCI vector biologist Anthony James, the Donald Bren Professor of Microbiology & Molecular Genetics and Molecular Biology & Biochemistry, who was a co-primary investigator on the study.
“The second-generation gene drive system described in this paper can be applied to any of the several thousand genes that are essential for insects to survive or reproduce,” said UC San Diego Distinguished Professor Ethan Bier, a co-author of the study and science director at the Tata Institute for Genetics and Society. “While it was developed in fruit flies, this system is readily transportable to a broad selection of insect species that serve as vectors for devastating disorders such as Chagas disease, sleeping disease, leishmaniasis and arboviral diseases.”
Study results appear in Nature Communications. Link to study: https://www.nature.com/articles/s41467-020-19426-0
They describe a highly efficient second-generation version of the team’s original gene drive, developed for the Indo-Pakistani malaria vector mosquito Anopheles stephensi. The 2015 work, published in Proceedings of the National Academy of Sciences, was the first demonstration of a CRISPR-based gene drive in mosquitoes.
In that first study, the gene drive was transmitted to about 99 percent of progeny when the parent in which the gene drive was inserted was a male but only 60 to 70 percent of offspring when the parent in which the gene drive was inserted was a female. A significant number of drive-resistant chromosomes are generated in females; this, in principle, could allow those females to continue to transmit parasites.
Adolfi, lead author of the new study, and collaborators solved the failure to drive efficiently through females by equipping the gene drive with a functional copy of the target gene into which the drive is inserted. Normal function of this target gene is required in this mosquito species for female survival and fertility after she feeds on blood, and its functionality is usually disrupted when the drive system is inserted into the gene.
The resulting female mosquitoes showed strong and consistent drive in a population cage study and negligible production of drive-resistant chromosomes. This strategy of inserting a gene drive into a gene essential for viability or fertility and at the same time including a functional gene that rescues the loss of viability or fertility provides a general solution to drive resistance through females. Also, as with a catalytic converter removing combustion pollution from automobiles, the new system efficiently eliminates genetic errors made in the drive process.
This gene drive system – in combination with genes for blocking parasite transmission – can now be used to design field-ready strains of mosquitoes. Thorough testing is required to demonstrate safety and efficacy before advancing to field testing.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Blocking malaria transmission
- DeepMind research predicts structure of almost every known protein
The breakthrough will help to tackle major global challenges such as developing malaria vaccines and fighting plastic pollution.
- Artificial intelligence has mapped out every protein known to science
Artificial intelligence has mapped out the shape of virtually every protein known to science. The breakthrough will help to tackle major global challenges such as developing malaria vaccines and ...
- DeepMind research predicts structure of almost every known protein
which is one of the most promising candidates for inclusion in a transmission-blocking malaria vaccine. Existing technology alone did not allow them to fully understand the structure of the ...
Go deeper with Google Headlines on:
Blocking malaria transmission
Go deeper with Bing News on:
CRISPR-based gene drive
- High Cholesterol CRISPR Cure Enters Human Trial
New CRISPR based gene therapy aims to permanently deactivate a gene in the liver that regulates the production of PCSK9, a protein that prevents the body from removing excess cholesterol. In trials ...
- CRISPR And CAS Gene Technology Market Is Booming With Rising Investments In Digitalization Globally By 2030
Research Nester released a report titled “CRISPR and CAS Gene Technology Market : Global Demand Analysis & Opportunity Outlook 2030” ...
- 10 years of magic scissors that could cut out most diseases
Crsipr, a gene-editing technology, has led to innovations in medicine, evolution and agriculture — but at the same time it's also raised profound ethical questions about altering human DNA ...
- CRISPR and CAS Gene Market – Increasing focus of researchers on developed a new genome editing tool is expected to boost the growth of the market
Market players in the market and scientists are aiming on the growth of new pooled public library to show CRISPR scientists. For example, in June 2019, Cellecta, Inc. approved dual-sgRNA libraries ...
- Using CRISPR to Lift the Lid on Probiotics
For your latest research, you used CRISPR-Cas. With this still being a relatively new gene-editing technology ... again bacteriophage attacks (my PI Dr. Rodolphe Barrangou actually first reported ...